Arcturus Therapeutics expects interim results for LUNAR-CF and LUNAR-OTC in 2025. Learn why ARCT stock presents an ...
Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback